study
-
Biologics
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
–Two-Year Follow-Up Results Confirm Significant Efficacy and No Serious Adverse Effects in Patients who Underwent the StemSpine® Procedure for Treating…
Read More » -
Sports Medicine
Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study
Implantable shock absorber demonstrates clinically meaningful pain relief and functional improvement in data presented at OSET September 23, 2022 FREMONT,…
Read More » -
Biologics
Innovative Spinal Biomaterial Demonstrates Early Healing in Retrospective Study
ZFUZE Shows 91.4% Fusion Rates at 8 Months AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) — DiFusion, Inc., an Austin,…
Read More » -
Spine
Premia Spine’s TOPS™ Spinal Joint Replacement Shows Potential to Relieve Back Pain and Maintain Mobility Without Adjacent Level Degeneration
Case series published in Operative Neurosurgery evaluates long-term data on motion-preserving alternative to fusion. September 7, 2022 NORWALK, Conn.–(BUSINESS WIRE)–Premia…
Read More » -
Recon
Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
Study achieved primary and key secondary endpoints of statistically significant reductions in postsurgical pain and opioid consumption through 96 hours.…
Read More » -
Recon
Knee Arthroplasty Market Is Likely to Reach USD 13928.96 million with Growing CAGR Of 6.00% forecast By 2029
Patients are becoming more aware of the advantages of surgery over alternative forms of treatment including medication and physical therapy,…
Read More » -
Spine
Interspinous Spacers Market is Estimated to Progress at CAGR of 6.09% during Forecast Period, notes TMR Study
For persons over 65 years undergoing spine surgery, LSS is the most common preoperative diagnosis. Therefore, rising number of elderly…
Read More » -
Biologics
Zavation releases In-Vitro and In-Vivo Research Summary for its novel “LABYRINTH™”
JACKSON, Miss., Aug. 10, 2022 /PRNewswire/ — Zavation Medical Products (“Zavation” or the “Company”), an innovative designer and manufacturer of spinal implants,…
Read More » -
Spine
SynerFuse™ Announces Fifth Patient Implanted in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study
Study to Evaluate Safety and Tolerability of Simultaneous Implant of Spinal Fusion and Neuromodulation Devices in Chronic Lower Back Pain…
Read More » -
Neuro
InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery
Manuscript details patient outcomes through 24-month follow up visit June 8, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today…
Read More » -
Spine
Study Data Show Premia Spine’s TOPS™ Spinal Arthroplasty System Is Cost-effective Compared With TLIF, Becomes Dominant Strategy Over Time
First-of-a-kind TOPS System designed to offer treatment alternative for patients with spinal stenosis and spondylolisthesis June 2, 2022 NORWALK, Conn.–(BUSINESS…
Read More » -
Spine
InVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury Study
Topline data expected to be reported in Q1 2023 June 2, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV),…
Read More » -
Spine
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing…
Read More » -
Spine
Karolinska Development’s portfolio company OssDsign completes patient enrollment to the TOP FUSION study
STOCKHOLM, SWEDEN, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign has enrolled…
Read More » -
Spine
Spineart-100 U.S. Patients Treated In The Single Level IDE Clinical Trial Of BAGUERA®C Cervical Disc Prosthesis
LAGUNA HILLS, Calif., April 21, 2022 /PRNewswire/ — Spineart USA Inc. announced today that surgery has been performed on 100 patients in the single-level U.S.…
Read More »